"好人好报"捐赠仪式现场。西海新闻记者 季蓉 摄 共和路社区居民在道德讲堂内，共同翻阅获赠的《西海都市报》，关注本地民生新闻。西海新闻记者 马小玮 摄 ↑社区工作人员认真翻阅获赠的《西海都市报》，从中了解民生资讯与政策动态。西海新闻记者 马小玮 摄 "我们长期深耕公益领域，常态化在社区开展义诊等便民服务。"西宁宏明康医院办公室主任席宁坦言，"好人 好报"活动搭建了广阔的爱心平台，既传递了正能量，又为社区好人送去了精神食粮。这家省卫生部门批准设 立的精神心理科专科医院，始终以专业力量守护市民心理健康。 当日15时，活动现场早已布置妥当，红色横幅映衬着居民们的笑脸。伴随着轻快的背景音乐，赠报仪式拉开 帷幕。签到入场环节，主持人热情引导，获赠居民有序签到后，在指定区域就座，医院代表与社区工作人员 悉数就位，现场秩序井然。 开场致辞中，西海都市报主持人耿永娇介绍本次活动的初衷："一份报纸，连接的是爱心与民生；一次赠报， 传递的是温暖与担当。感谢4家医院的善举，让社区里的好人们收获这份特别的精神食粮。"简短的话语，道 出了在场所有人的心声。 爱心单位发言环节，西宁仁爱妇科医院办公室主任乔峰作为代表登台，他说："为社区好 ...

本报讯 记者从海口市人民医院获悉，为持续提升诊疗水平，该院特邀国内知名心血管专家肖锋教授 为"特聘专家"。今年起，肖锋将定期每月在该院开展高难度手术指导、疑难病例教学查房及团队技术培 养，持续提升心脏外科领域诊疗能力；也让疑难重症患者无需远行，即可享受到国内顶尖的手术技术与 治疗方案指导。 记者 钟起的 肖锋教授2000至2024年任北京大学第一医院心血管外科主任，长期工作在临床一线，帮助全国160多家 医院开展冠状动脉搭桥手术及心脏外科手术，累计完成心血管外科手术2万多例。手术技术全面，在复 杂瓣膜手术、大血管手术、主动脉夹层、全胸腹主动脉置换、复杂先天性心脏病手术、心脏移植、左室 辅助及人工心脏等领域均有深厚造诣，是国内冠状动脉搭桥手术的先行者之一，最早在国内应用桡动脉 进行搭桥手术。 ...

经初步了解，此事系当事人李某某在某工地施工受伤后，涉及工伤待遇问题引发，与我院医疗及服务工 作无关。事件发生后，我院高度重视，第一时间配合公安、消防、政法委等部门开展现场疏导与处置工 作，全力维护现场秩序，保障就诊患者、家属及医护人员安全。目前现场情况已恢复平稳，院内诊疗活 动正常有序进行，相关工伤纠纷已由相关部门依法受理并跟进处理。 1月4日，海南省人民医院发布情况说明，2026年1月4日上午，我院门诊楼楼顶发生一起市民欲跳楼事 件，引发现场群众关注。为澄清事实、避免误解，现就有关情况说明如下： 来源：海南省人民医院官方平台 在此，我们呼吁公众客观理性看待此事，不传播不实信息，不将医疗机构与无关社会纠纷简单关联，共 同维护和谐稳定的医疗环境。 转自：北京日报客户端 ...

Group 1: Project Overview - The "Mars Science City" project is set to begin construction in the second half of 2026, with a total planned area of 62 acres, including 90,000 square meters of above-ground space and 100,000 square meters underground, aiming for trial operations in 2028 and official opening in 2029 [2] - The project will leverage resources from Tsinghua University and the Chinese Academy of Sciences, creating a high-quality, differentiated cultural tourism ecosystem in Beijing's sub-center [2] Group 2: Educational and Entertainment Aspects - "Mars Science City" will integrate cutting-edge technologies such as aerospace, artificial intelligence, and robotics into its narrative, allowing visitors to engage in a storyline focused on survival, exploration, and construction on Mars [2] - The project aims to become a second classroom for youth and a family-friendly science leisure destination, enhancing public scientific literacy through immersive experiences and interactive activities [2] Group 3: Urban Development and Infrastructure - During the "14th Five-Year Plan" period, the sub-center will continue to strengthen its core strategic tasks, including the relocation of eight state-owned enterprises and the completion of educational institutions like Tsinghua University's financial development base [3] - The sub-center will establish a modern, high-quality comprehensive transportation network, with the completion of the M101 line and the northern extension of the Yizhuang line, enhancing accessibility [3] Group 4: Healthcare Development - The number of tertiary medical institutions in the Beijing urban sub-center has reached eight, with ongoing improvements in the grassroots medical network [6] - There are ongoing efforts to address challenges in cardiovascular disease prevention and treatment, including the establishment of a quality control network for community health services [6]

Group 1 - The article discusses the importance of establishing a "safe base" for children's psychological recovery, emphasizing the role of parents and caregivers in providing emotional support [1] - It highlights the expertise of Dr. Huang Xuebing and Wang Yulu in mental health, particularly in the areas of clinical psychological treatment and family therapy [1] - The article references a resource titled "Sunshine New Sprout: A Popular Science Book on Depression for Adolescents and Parents," indicating a focus on educating families about mental health [1]

Investment Rating - The report maintains a "Recommended" rating for several companies in the healthcare sector, including Weili Medical, Zhend Medical, Aohua Endoscopy, and others [33]. Core Insights - The report highlights a shift in the innovative drug sector from quantity to quality, emphasizing the importance of differentiated products and internationalization for future profitability [11]. - The medical device sector is experiencing a recovery in bidding volumes, particularly in imaging equipment, and is expected to benefit from government subsidies for home medical devices [11][19]. - The life sciences service sector is showing signs of recovery, with increasing demand driven by both domestic and international markets [23]. - The pharmacy sector is poised for growth due to the acceleration of prescription outflow and an improving competitive landscape [24]. Summary by Sections Market Review - The report notes a 2.02% decline in the CITIC Medical Index, underperforming the CSI 300 Index by 1.44 percentage points, ranking 27th among 30 sectors [7]. Innovative Drugs - The innovative drug sector is expected to see a significant increase in the number of products launched, with projections of over 30 products by 2027, and a revenue share from innovative products expected to exceed 50% by 2025 [15]. Medical Devices - The report identifies a recovery in bidding for imaging devices and highlights the potential for domestic companies to increase market share through product upgrades and international expansion [19][20]. Life Sciences Services - The life sciences service sector is anticipated to benefit from a recovery in overseas demand and an increase in domestic industrial demand, with a focus on mergers and acquisitions to strengthen market positions [23]. Pharmacies - The pharmacy sector is expected to benefit from the acceleration of prescription outflow and an improved competitive landscape, with recommendations to focus on leading pharmacy chains [24]. Traditional Chinese Medicine - The report emphasizes the importance of basic medicines and state-owned enterprise reforms, suggesting a focus on companies like Kunming Pharmaceutical and Kangyuan Pharmaceutical [27]. Medical Services - The report recommends focusing on companies with national expansion capabilities in the medical services sector, particularly those in traditional Chinese medicine and ophthalmology [26]. Blood Products - The blood products sector is expected to see growth due to relaxed approval processes for plasma stations and an increase in product offerings [12].

海南自贸港药品、医疗器械"零关税"政策明确，在博鳌乐城国际医疗旅游先行区内注册登记具有独立法 人资格并经认定的医疗机构、医学教育高等院校、医疗类科研院所，进口政策规定范围内的药品、医疗 器械，可享受免征进口关税、进口环节增值税和消费税，降低医疗机构运营成本，更为患者就医显著减 轻负担。 央广网海口1月4日消息（记者 蔡文娟）自2024年12月31日首票业务落地以来，海南自贸港药品、医疗 器械"零关税"政策已平稳运行一周年，政策红利持续释放。据海口海关统计，截至2025年12月31日，累 计进口"零关税"药械货值约4.6亿元，减免税款约6200万元。 "这项政策对于我们这些在乐城内注册的医疗机构来说可谓是'锦上添花'，不仅可以减轻患者用药用械 成本，也为我们企业资金周转提供了很大的便利。"海南博鳌超级医院相关负责人冯家龙说。 为保障"零关税"药械政策实施，海口海关积极研究优化通关流程，深入走访调研了解不同类型企业享惠 政策堵点痛点，研提解决措施，让政策红利精准触及享惠主体。 ...

Group 1 - The core viewpoint of the article emphasizes the importance of Nanjing's selection as a pilot project for public hospital reform and high-quality development by 2025, aiming to meet the health needs of the people [1] - The city will strictly follow national and provincial policies, implementing the municipal government's opinions and requirements for advancing the pilot project [1] - The goal is to establish Nanjing as a health hub in the Yangtze River Delta, seizing opportunities and fostering innovation to ensure the effective implementation of the pilot project [1] Group 2 - Nanjing will adopt a high-level coordination approach, learning from the Sanming medical reform experience to promote overall reform and enhance service collaboration [2] - The focus will shift from disease treatment to prioritizing people's health, demonstrating the integration of the "three medical" systems [2] - The city aims to enhance medical service capabilities by addressing complex and severe cases, creating a medical service structure that includes peak medical institutions and grassroots networks [2] - There will be an emphasis on building an integrated healthcare service system, promoting tightly-knit urban medical groups and county-level medical communities [2] - The city plans to strengthen party leadership, reform personnel and salary systems, and adjust medical service prices dynamically to ensure sustainable operations [2] - Nanjing will promote information sharing and develop a comprehensive health network, integrating new technologies with health services to provide more precise and convenient healthcare for the public [2]

Investment Rating - The report maintains a "Buy" rating for the medical services industry [5][66]. Core Insights - The medical and biological sector experienced a decline of 2.06% this week, ranking 28th among 31 primary industries [1][11]. - The AI pharmaceutical company Insilico Medicine was listed on the Hong Kong Stock Exchange, raising HKD 2.277 billion, marking it as the highest fundraising biotech IPO in 2025 [4][63]. - AI technology is significantly reducing the time and costs associated with drug discovery and clinical trials, with potential savings of approximately USD 26 billion annually in compound screening and clinical trial costs [5][65]. Summary by Sections Industry Performance - The medical services sector's PE (ttm) is 31.28X, with a PB (lf) of 3.17X, showing a decrease of 0.52X in PE and 0.05X in PB from the previous week [3][30]. - The medical services II sub-industry index closed at 6363.18 points, down 1.40% [22][23]. Company Performance - Top-performing companies in the medical services sector include: - Purui Eye Hospital (+5.3%) - Sanbo Brain Science (+4.7%) - Puris (+3.0%) - Tigermed (+2.9%) - Baicheng Pharmaceutical (+2.2%) - Underperforming companies include: - Bid Pharmaceutical (-6.6%) - Sunshine Nuohua (-6.1%) - Zhaoyan New Drug (-5.2%) - International Medicine (-4.0%) - Kanglong Chemical (-3.5%) [2][28]. Investment Recommendations - The report suggests focusing on high-growth areas such as ADC CDMO and peptide CDMO in the pharmaceutical outsourcing services, with companies like WuXi AppTec, Haoyuan Pharmaceutical, and WuXi Biologics being highlighted [9][66]. - It also recommends looking at third-party medical testing laboratories and consumer healthcare sectors, particularly in ophthalmology and dentistry, with companies like Aier Eye Hospital and Dean Diagnostics [9][66].

Core Viewpoint - The book "Jin Yamei: A Zhejiang Woman Going Global" by Lou Weining highlights the life and contributions of Jin Yamei (also known as Jin Yunmei), the first female medical doctor in China, emphasizing her role in modernizing and facilitating cultural exchanges between China and the West [2][26]. Group 1: Author and Book Overview - The author, Lou Weining, is an English teacher who has dedicated years to translating and interpreting Jin Yamei's life, incorporating materials from the American Soybean Research Center [2]. - The book features a bilingual format, which may aid Chinese readers in understanding the content better [2]. Group 2: Jin Yamei's Background and Education - Jin Yamei, orphaned at a young age, was adopted by missionaries and had various names in different documents due to the lack of a formal Chinese name [4]. - She graduated first in her class from the Women's Medical College of the New York Infirmary in 1885, becoming the first Chinese woman to earn a medical doctorate [10][12]. Group 3: Professional Journey and Challenges - After her graduation, Jin Yamei faced challenges in obtaining a medical license in the U.S., which was complicated by the administrative disarray in Hawaii at the time [11]. - She worked as a missionary doctor in Xiamen and later established a private practice in Kobe, Japan, where she faced health issues due to the local environment [11][10]. Group 4: Advocacy and Public Speaking - Jin Yamei transitioned from clinical practice to public speaking, addressing cultural differences and the realities faced by Chinese immigrants in America [15][19]. - She conducted a series of lectures across major U.S. cities, discussing various topics including science, history, and Eastern culture, which helped raise awareness of the Chinese community's struggles [16][19]. Group 5: Legacy and Impact - Jin Yamei's life and work symbolize the emergence of modern Chinese women and their contributions to society, particularly in the fields of medicine and cultural exchange [26]. - The book serves as a valuable resource for understanding the development paths of female elites who ventured beyond the Chinese cultural sphere during the late Qing period [26].